FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dominique de Valeriola

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Objects

Cancer Care Facilities

Organizations

European Union

Co-author Network

Publications

TOP 3
Ahmad Awada; S Bartholomeus; Erich Brendel; Olaf Christensen; Dominique de Valeriola; Thierry Delaunoit; Alain Hendlisz; Chetan D Lathia; Fabienne Lebrun; Martine J Piccart-Gebhart; Martin Radtke; Thierry Gil
Phase I trial to investigate the safety, pharmacokinetics and efficacy of sorafenib combined with docetaxel in patients with advanced refractory solid tumours.
Mahasti Saghatchian; Henk Hummel; Renée Otter; Dominique de Valeriola; Wim Van Harten; angelo paradiso; Bert Koot; Ulrik Ringborg; Thomas Tursz
Towards quality, comprehensiveness and excellence. The accreditation project of the Organisation of European Cancer Institutes (OECI).
Ulrik Ringborg; Dominique de Valeriola; Wim van Harten; Antonio Llombart Bosch; Claudio Lombardo; Kenneth Nilsson; Thierry Philip; Marco A Pierotti; Peter Riegman; Mahasti Saghatchian; Guy Storme; Thomas Tursz; Dirk Verellen
Improvement of European translational cancer research. Collaboration between comprehensive cancer centers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dominique de Valeriola (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Ahmad Awada; S Bartholomeus; Erich Brendel; Olaf Christensen; Dominique de Valeriola; Thierry Delaunoit; Alain Hendlisz; Chetan D Lathia; Fabienne Lebrun; Martine J Piccart-Gebhart; Martin Radtke; Thierry Gil
Phase I trial to investigate the safety, pharmacokinetics and efficacy of sorafenib combined with docetaxel in patients with advanced refractory solid tumours.
European journal of cancer (Oxford, England : 1990) 2012;48(4):465-74.
2008: Mahasti Saghatchian; Henk Hummel; Renée Otter; Dominique de Valeriola; Wim Van Harten; angelo paradiso; Bert Koot; Ulrik Ringborg; Thomas Tursz
Towards quality, comprehensiveness and excellence. The accreditation project of the Organisation of European Cancer Institutes (OECI).
Tumori 2008;94(2):164-71.
2008: Ulrik Ringborg; Dominique de Valeriola; Wim van Harten; Antonio Llombart Bosch; Claudio Lombardo; Kenneth Nilsson; Thierry Philip; Marco A Pierotti; Peter Riegman; Mahasti Saghatchian; Guy Storme; Thomas Tursz; Dirk Verellen
Improvement of European translational cancer research. Collaboration between comprehensive cancer centers.
Tumori 2008;94(2):143-6.
2007: Ahmad Awada; Steven Zhang; Thierry Gil; Dominique de Valeriola; Yassine Lalami; Peter De Porre; Martine J Piccart-Gebhart
A phase I clinical and pharmacokinetic study of tipifarnib in combination with docetaxel in patients with advanced solid malignancies.
Current medical research and opinion 2007;23(5):991-1003.
2006: Angelo Paci; Keyvan Rezai; Alain Deroussent; Dominique de Valeriola; Micheline Re; Sophie Weill; Esteban Cvitkovic; Carmen Kahatt; Ajit Shah; Stephen Waters; Gary Weems; Gilles Vassal; François Lokiec
Pharmacokinetics, metabolism, and routes of excretion of intravenous irofulven in patients with advanced solid tumors.
Drug metabolism and disposition: the biological fate of chemicals 2006;34(11):1918-26.
2005: Martine J Piccart; Dominique de Valeriola; L Dal Lago; Evandro de Azambuja; Gaston Demonty; Fabienne Lebrun; Chantal Bernard-Marty; Mariantonietta Colozza; T Cufer
Adjuvant chemotherapy in 2005: standards and beyond.
Breast (Edinburgh, Scotland) 2005;14(6):439-45.
2005: Ahmad Awada; Alain Hendlisz; Thierry Gil; S Bartholomeus; M Mano; Dominique de Valeriola; Dirk Strumberg; Erich Brendel; Claus G Haase; Brian Schwartz; Martine Piccart
Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours.
British journal of cancer 2005;92(10):1855-61.
2004: Ahmad Awada; Thierry Gil; François Sales; M Dubuisson; Pierre Vereecken; J Klastersky; C Moerman; Dominique de Valeriola; Martine J Piccart
Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancers.
Anti-cancer drugs 2004;15(5):499-502.
2002: Ahmad Awada; S Giacchetti; Béatrice Gerard; P Eftekhary; Catherine Lucas; Dominique de Valeriola; Marie-Gwenaëlle Poullain; J Soudon; C Dosquet; M-H Brillanceau; B Giroux; Michel Marty; Harry Bleiberg; F Calvo; Martine Piccart
Clinical phase I and pharmacokinetic study of S 16020, a new olivacine derivative: report on three infusion schedules.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(12):1925-34.
2002: A Hamilton; Laura Biganzoli; R Coleman; Louis Mauriac; Philippe Hennebert; Ahmad Awada; Marianne A Nooij; Louk V A M Beex; Martine Piccart; I Van Hoorebeeck; Peter Bruning; Dominique de Valeriola
EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx, Doxil) at a 6-week interval in patients with metastatic breast cancer. European Organization for Research and Treatment of Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(6):910-8.
2002: Gilles Freyer; Philippe Hennebert; Ahmad Awada; Thierry Gil; Joseph Kerger; Jean Selleslags; Christiane Brassinne; Martine Piccart; Dominique de Valeriola
Influence of amifostine on the toxicity and pharmacokinetics of docetaxel in metastatic breast cancer patients: a pilot study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(1):95-102.
2000: E Van Den Neste; Dominique de Valeriola; Joseph Kerger; Harry Bleiberg; Z Kusenda; C Brassinne; S Bartholomeus; J Selleslags; Philippe Hennebert; H Wythouck; I Cazenave; F Lefresne-Soulas; Martine Piccart
A phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(1):64-71.
1997: Dominique de Valeriola; Ahmad Awada; Josee-Anne Roy; A Di Leo; Laura Biganzoli; M Piccart
Breast cancer therapies in development. A review of their pharmacology and clinical potential.
Drugs 1997;54(3):385-413.